nitroglycerin
| Form | Strength |
|---|---|
| CAPSULE, EXTENDED RELEASE, ORAL | 2.5 mg; 6.5 mg; 9 mg |
| FILM, EXTENDED RELEASE, TRANSDERMAL | 0.1 mg/hr; 0.2 mg/hr; 0.3 mg/hr; 0.4 mg/hr; 0.6 mg/hr; 0.8 mg/hr |
| OINTMENT, TRANSDERMAL | 2% |
| SOLUTION, INTRAVENOUS | 5 mg/mL; 100 mcg/mL-D5%; 200 mcg/mL-D5%; 400 mcg/mL-D5% |
| SPRAY, SUBLINGUAL | 0.4 mg |
| TABLET, SUBLINGUAL | 0.4 mg |
For Titration Guidelines See Policy 900.3028
Patch Specific Pharmaceutical Waste Guide: See Protocol 900.4412
2% ointment - for use in treatment of extravasation: please refer to Elsevier Clinical Skills: Prevention and Management of Extravasations for the Treatment and Management of Extravasations.